Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Peritonitis carcinomatosa van colorectaal carcinoom : Nieuwe behandelmogelijkheden

Verwaal, Victor J. LU ; De Hingh, Ignace H.J.T. and Boot, Henk (2015) In Nederlands Tijdschrift voor Geneeskunde 159(47).
Abstract

• Peritonitis carcinomatosa occurs in 10% of patients with colorectal carcinoma. • Compared with patients with lung and liver metastases, survival in patients with peritonitis carcinomatosa is worse if treated with systemic chemotherapy. However, treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) offers longer survival than systemic chemotherapy. • A Dutch registration study shows that the 3- and 5-year survival of patients treated with cytoreductive surgery and HIPEC had a 3-year survival of 46% and a 5-year survival of 31%. • Mortality and morbidity have dropped greatly due to standardisation of the intervention in accordance with the Dutch protocol.

Please use this url to cite or link to this publication:
author
; and
alternative title
Peritonitis carcinomatosa from colorectal carcinoma : New treatment options
publishing date
type
Contribution to journal
publication status
published
in
Nederlands Tijdschrift voor Geneeskunde
volume
159
issue
47
article number
A9319
publisher
Bohn Stafleu van Loghum
external identifiers
  • pmid:26556491
  • scopus:84947749887
ISSN
0028-2162
language
Dutch
LU publication?
no
additional info
Original language: Dutch
id
257039bc-15df-4a27-bb04-0f9b69d4ad8b
alternative location
https://www.ntvg.nl/system/files/publications/a9319.pdf
date added to LUP
2022-04-12 11:02:47
date last changed
2024-01-06 23:40:12
@article{257039bc-15df-4a27-bb04-0f9b69d4ad8b,
  abstract     = {{<p>• Peritonitis carcinomatosa occurs in 10% of patients with colorectal carcinoma. • Compared with patients with lung and liver metastases, survival in patients with peritonitis carcinomatosa is worse if treated with systemic chemotherapy. However, treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) offers longer survival than systemic chemotherapy. • A Dutch registration study shows that the 3- and 5-year survival of patients treated with cytoreductive surgery and HIPEC had a 3-year survival of 46% and a 5-year survival of 31%. • Mortality and morbidity have dropped greatly due to standardisation of the intervention in accordance with the Dutch protocol.</p>}},
  author       = {{Verwaal, Victor J. and De Hingh, Ignace H.J.T. and Boot, Henk}},
  issn         = {{0028-2162}},
  language     = {{dut}},
  number       = {{47}},
  publisher    = {{Bohn Stafleu van Loghum}},
  series       = {{Nederlands Tijdschrift voor Geneeskunde}},
  title        = {{Peritonitis carcinomatosa van colorectaal carcinoom : Nieuwe behandelmogelijkheden}},
  url          = {{https://www.ntvg.nl/system/files/publications/a9319.pdf}},
  volume       = {{159}},
  year         = {{2015}},
}